Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

Gut

Volumn 52, Issue 10, 2003, Pages 1397-1402

  Koek, G H ^a,b   Sifrim, D ^a   Lerut, T ^a   Janssens, J ^a   Tack, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG EFFECT; DRUG MEGADOSE; DRUG TOLERABILITY; DUODENOGASTRIC REFLUX; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAINTENANCE DRUG DOSE; MALE; NAUSEA; PH MEASUREMENT; PRIORITY JOURNAL; SORE THROAT; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; BACLOFEN; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DUODENOGASTRIC REFLUX; ESOPHAGOSCOPY; FEMALE; GABA AGONISTS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; STATISTICS, NONPARAMETRIC;

EID: 0141757445     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.10.1397     Document Type: Article

References (30)

1. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
2. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992;51(suppl 1):24-9.
3. Dehn TCB, Sheperd HA, Colin-Jones D, et al. Double blind comparison of omeprazole versus cimetidine in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring. Gut 1990;31:509-13.
4. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
5. Klinkenberg-Knol E, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology 2000;118:661-9.
6. Robinson M, Campbell DR, Sontag S, et al. Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Dig Dis Sci 1995;40:590-7.
7. Marshall RE, Anggiansah A, Manifold DK, et al. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's esophagus. Gut 1998;43:603-6.
8. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001;96:331-7.
9. Stein HJ, Kauer WK, Feussner H, et al. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998;2:333-41.
10. Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-54.
11. Hollowey RH, Dent J, Narielvala F, et al. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole. Gut 1996;38:649-54.
12. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and esophageal 24-hour pH monitoring and esophageal manometry in patients with reflux disease resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4:485-95.
13. Tack J, Koek G, Demedts I, et al. Gastro-esophageal reflux disease poorly responsive to proton pump inhibitors: acid reflux, bile reflux or both? 2002(submitted for publication).
14. Wilmer A Tack J, Frans E, et al. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999;116:1293-9.
15. Vela M, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001;120:1599-606.
16. Vaezi MF, Sears-R, Richter JE. Placebo-controlled trial of cisapride in postgastrectomy patients with duodenogastroesophageal reflux. Dig Dis Sci 1996;41:754-63.
17. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547-52.
18. Schoeman MN, Tippett MD, Akkermans LMA, et al. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995;108:83-91.
19. Penagini R, Schoeman MN, Dent J, et al. Motor events underlying gastroesophageal reflux in ambulant patients with reflux esophagitis. Neurogastroenterol Mol 1996;8:131-41.
20. Sifrim D, Holloway R, Silny J, et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96:647-55.
21. Lidums I, Lehmann A Checklin H, et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000;118:7-13.
22. Zhang Q, Lehmann A, Checklin H, et al. Control of transient lower oesophageal relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002;50:19-24.
23. Tack J, Koek GH, Bisschops R, et al. Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 2003;48:1213-20.
24. Savary M, Miller G. L'oesophage. Manuel et Atlas d'Edoscopie. Solothurn, Switzerland: Verlag Gassmann, 1977.
25. Cuomo R, Koek G, Sifrim D, et al. Analysis of ambulatory duodeno-gastroesophageal reflux monitoring. Dig Dis Sci 2001;45:2463-9.
26. Hirschowitz BI. A critical analysis, with appropriate controls of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991;101:1149-58.
27. Holloway RH, Dent J. Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors. Dig Dis 2000;18:7-13.
28. McDermott CM, Abrahams TP, Partosoedarso E, et al. Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats. Gastroenterology 2001;120:1749-62.
29. Freidin N, Fisher MJ, Taylor W, et al. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut 1991;32:1275-9.
30. Marshall RE, Anggiansah A, Owen WA, et al. The extent of duodenogastric reflux in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2001;13:5-10.